Here are five highlights.
1. The analysts predict the sales could land between $106.9 million and $108.4 million for the first quarter.
2. In the first quarter of 2017, Orthofix saw sales of $102.74 million, reflecting a 4.8 percent year-over-year growth between 2017 and 2018.
3. Zacks anticipates Orthofix will report full-year sales of $456.1 million.
4. Full-year sales could range between and $453.5 million and $460 million.
5. Orthofix will officially report its earnings results May 3.
More articles on devices:
Xtant Medical forms new partnership to extend medical device access: 3 insights
15 spine devices receive FDA 510(k) clearance in March 2018
1st spine surgery with SpineGuard’s PediGuard performed in China — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
